HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Shigellosis — Clinical Guidelines

Overview

Shigellosis is an infectious diarrheal disease caused by Shigella species, leading to bacillary dysentery, particularly in regions with poor hygiene and sanitation 1. Despite the lack of a licensed vaccine, research focuses on developing subunit vaccines targeting specific antigenic proteins and O-specific polysaccharide domains 1 2.

Diagnosis

Clinical Presentation: Bloody diarrhea, fever, abdominal pain 1.

Microbiological Tests: Stool culture remains the gold standard for diagnosis 1.

Serological Tests: ELISA for detecting shigella toxin can aid in diagnosis, especially in identifying S. dysenteriae infections 5.

Immunological Markers: Monitoring serum zinc levels and shigellacidal antibody titers may provide additional insights in malnourished populations 3.

Management

First-Line Treatment: Antibiotic therapy, such as ciprofloxacin or azithromycin, tailored based on local resistance patterns 1.

Adjunctive Therapy: Zinc supplementation in malnourished children to enhance immune response and reduce duration of diarrhea 3.

Supportive Care: Fluid and electrolyte replacement to manage dehydration 1.

Special Populations

Pediatrics: Zinc supplementation (20 mg/day) may improve systemic immune responses in mildly to moderately malnourished children 3.

Comorbidities: No specific recommendations provided in the abstracts; general supportive care and tailored antibiotic therapy are advised 1.

Key Recommendations

Use of Antibiotics: Initiate appropriate antibiotic therapy based on local resistance patterns for treating shigellosis (Evidence: Strong 1).

Zinc Supplementation: Provide zinc supplementation (20 mg/day) for 14 days in malnourished children with shigellosis to enhance immune response (Evidence: Moderate 3).

Serological Monitoring: Consider serological markers like shigellacidal antibody titers for assessing immune response in clinical trials or specific patient groups (Evidence: Weak 3).

References

1 Allemailem KS, Alrumaihi F, Almatroudi A. Immunoinformatics-based design of a next generation multi-epitope vaccine candidate against Shigella boydii using a hierarchical subtractive proteomics approach. Scientific reports 2025. link 2 Kubler-Kielb J, Vinogradov E, Mocca C, Pozsgay V, Coxon B, Robbins JB et al.. Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates. Carbohydrate research 2010. link 3 Rahman MJ, Sarker P, Roy SK, Ahmad SM, Chisti J, Azim T et al.. Effects of zinc supplementation as adjunct therapy on the systemic immune responses in shigellosis. The American journal of clinical nutrition 2005. link 4 Johnson MA, Eniade AA, Pinto BM. Rational design and synthesis of peptide ligands for an anti-carbohydrate antibody and their immunochemical characterization. Bioorganic & medicinal chemistry 2003. link00449-2) 5 Donohue-Rolfe A, Kelley MA, Bennish M, Keusch GT. Enzyme-linked immunosorbent assay for shigella toxin. Journal of clinical microbiology 1986. link 6 Carlin NI, Lindberg AA, Bock K, Bundle DR. The Shigella flexneri O-antigenic polysaccharide chain. Nature of the biological repeating unit. European journal of biochemistry 1984. link 7 Freedlnder E, Manson R, Simmons DA. The immunochemistry of Shigella flexneri O-antigens: an analysis of the antigenic determinants of group factors. Immunology 1971. link 8 Simmons DA. The immunochemistry of Shigella flexneri O-antigens: an analysis of the determinants of some representative type specific factors. Immunology 1971. link

Shigellosis